Accuray (ARAY) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,114.00 |
| Dec 31, 2025 | -1,810.00 |
| Sep 30, 2025 | -2,345.00 |
| Jun 30, 2025 | -2,084.00 |
| Mar 31, 2025 | -366.00 |
| Dec 31, 2024 | -874.00 |
| Sep 30, 2024 | 646.00 |
| Jun 30, 2024 | 2,267.00 |
| Mar 31, 2024 | -491.00 |
| Dec 31, 2023 | -1,526.00 |
| Sep 30, 2023 | 443.00 |
| Jun 30, 2023 | 1,944.00 |
| Mar 31, 2023 | 925.00 |
| Dec 31, 2022 | 402.00 |
| Sep 30, 2022 | -1,182.00 |
| Jun 30, 2022 | 2,152.00 |
| Mar 31, 2022 | 364.00 |
| Dec 31, 2021 | 1,079.00 |
| Sep 30, 2021 | 485.00 |
| Jun 30, 2021 | 3,802.00 |
| Mar 31, 2021 | -108.00 |
| Dec 31, 2020 | 996.00 |
| Sep 30, 2020 | 1,462.00 |
| Jun 30, 2020 | 5,444.00 |
| Mar 31, 2020 | 543.00 |
| Dec 31, 2019 | 2,081.00 |
| Sep 30, 2019 | 1,543.00 |
| Jun 30, 2019 | -3,296.00 |
| Mar 31, 2019 | 298.00 |
| Dec 31, 2018 | 70.00 |
| Sep 30, 2018 | 1,019.00 |
| Jun 30, 2018 | -10,361.00 |
| Mar 31, 2018 | 3,508.00 |
| Dec 31, 2017 | 2,720.00 |
| Sep 30, 2017 | 1,630.00 |
| Jun 30, 2017 | 2,173.00 |
| Mar 31, 2017 | 899.00 |
| Dec 31, 2016 | -90.00 |
| Sep 30, 2016 | 1,522.00 |
| Jun 30, 2016 | -3,708.00 |
| Mar 31, 2016 | 233.00 |
| Dec 31, 2015 | -1,281.00 |
| Sep 30, 2015 | -189.00 |